Development of pharmacological strategies for mitochondrial disorders. - Wikidata - wikimedia - TriplyDB

Development of pharmacological strategies for mitochondrial disorders.

Development of pharmacological strategies for mitochondrial disorders.

http://www.wikidata.org/entity/Q37686237

about

Signal transducer and activator of transcription 2 deficiency is a novel disorder of mitochondrial fission Potential compounds for the treatment of mitochondrial disease.The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome.Emerging therapies for mitochondrial disorders.TRNT1 deficiency: clinical, biochemical and molecular genetic features Emerging aspects of treatment in mitochondrial disorders.Targeting autophagy and mitophagy for mitochondrial diseases treatment.Mitochondrial biogenesis and neural differentiation of human iPSC is modulated by idebenone in a developmental stage-dependent manner.The effects of exercise and cold exposure on mitochondrial biogenesis in skeletal muscle and white adipose tissue NBAS mutations cause acute liver failure: when acetaminophen is not a culprit Mitochondrial pharmacology: energy, injury and beyond.A novel thymidine phosphorylase mutation in a Chinese MNGIE patient.Mitochondrial dynamics in the pathogenic mold Aspergillus fumigatus: therapeutic and evolutionary implications.

P2860

Q28115520-07EB2E8A-9CA3-45AB-BF92-6421F3F92B53 Q35847813-7B3468FF-CD43-4DB1-8B65-0226FF141FDA Q36853449-442C6E49-42B4-4832-A232-F987AF5C1CB5 Q36967723-C892DE72-5D08-419F-8AC9-10EF85312215 Q37059646-FFDC5A86-8F00-4A83-A88A-58038B45B4D0 Q38472989-E464CDBA-01B9-4AF4-9D20-5AC3B992ECB7 Q38622293-543FB57E-840F-4C5C-8F66-62BCEB09DD96 Q41039539-6C7F04C9-E915-4CDF-AF5C-532D928EDC6D Q41265647-F5C9AC4F-EEC2-4C38-A08F-F07D71B47D9C Q41928992-CAC4F0AF-C6BD-4630-9EA3-5F38B0B5CFEF Q42374835-B8A86EE4-1A05-4B38-8A24-76FD6B67DD91 Q48486385-78889742-D56C-4F16-AB0D-5535132BF130 Q52662725-811C67D7-E089-4784-901B-902FF76ACF71

P2860

Development of pharmacological strategies for mitochondrial disorders.

http://www.wikidata.org/entity/Q37686237

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Development of pharmacological strategies for mitochondrial disorders.

@en

Development of pharmacological strategies for mitochondrial disorders.

@nl

type

label

Development of pharmacological strategies for mitochondrial disorders.

@en

Development of pharmacological strategies for mitochondrial disorders.

@nl

prefLabel

Development of pharmacological strategies for mitochondrial disorders.

@en

Development of pharmacological strategies for mitochondrial disorders.

@nl

P1433

Q37686237-2DF93763-0C8D-4064-936C-B17B751EED47

P1476

Q37686237-8AA4968C-50CF-4BCB-AC76-9CDBF90347D4

P2093

Q37686237-829B4D65-3170-47AB-B3C5-FCC3B39D3BE0

Q37686237-A14C027E-4733-40A1-BD27-5CD55190FE2B

Q37686237-FF5730D8-28BE-4456-BBAB-0A5F8123C291

P275

Q37686237-6F5F7257-C22E-4795-A684-E47B1555D72B

P2860

Q37686237-02BB399C-BF17-4288-B4AD-4541470B60A0

Q37686237-042829E9-2682-42DC-8C1A-9A5B35F9EAD9

Q37686237-06457AEE-B576-469B-89D5-A734B7471C22

Q37686237-072918E9-9CEA-497B-830E-F5BFDCDD1195

Q37686237-084A6854-84A4-4DFD-A227-8591F7B5B63F

Q37686237-08EDDC1A-FCC0-4788-BDC5-842E4E4274FF

Q37686237-0A93A966-AF17-415F-A12A-5C7E7F313A13

Q37686237-0B0F5D3E-0C34-4A05-92A8-02933D67C126

Q37686237-102EF368-A85B-44C2-9FA7-DA29EDE53D35

Q37686237-10961251-45E9-462C-A25C-6B47FA4E7808

P304

Q37686237-5A24FD82-9219-41D8-B901-BC6BDF6AA0F0

P31

Q37686237-9F3CAB5B-BE12-4CB3-B781-903A4B2A3C6E

Q37686237-A584148D-A2D9-478A-B409-1D5FB1DABDC8

P356

Q37686237-C3A0951A-74F4-4C34-B86E-806BDC91BCB5

P407

Q37686237-3E36B5F4-F47F-44A5-8AAD-A3822DF73C72

P433

Q37686237-4183C83E-2928-4EB8-A246-0F850EAABE27

P478

Q37686237-AFEBEA01-8BBB-445E-926F-9F95D788E198

P5008

Q37686237-DC437BB7-F0D8-448D-8BD5-AAD3F174B05D

P577

Q37686237-C5121B15-D8A5-4C27-97A5-0AAAEEE8047C

P5875

Q37686237-A65030D8-E63C-44C2-9029-242F7D4F7215

P698

Q37686237-4D4F4EF0-38B6-4A3C-8BD4-0C4BDE12625D

P921

Q37686237-2C46041C-B86D-47CC-A453-A7913FE4DEFE

Q37686237-376FEBDF-2A7A-48E2-BA4E-CB0FF8DA0188

Q37686237-6D73B940-9721-4CC4-B0C7-D5F62B89CF98

Q37686237-E81936C6-7EA8-4265-BEF3-EACA526A6F47

P932

Q37686237-7D632033-AADA-4EBB-99CC-A312D8E837C7

P356

P1433

British Journal of Pharmacology

P1476

Development of pharmacological strategies for mitochondrial disorders.

@en

P2093

M Kanabus

http://www.w3.org/2001/XMLSchema#string

S J Heales

http://www.w3.org/2001/XMLSchema#string

S Rahman

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Treatment for mitochondrial disorders

OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

Supercomplexes in the respiratory chains of yeast and mammalian mitochondria

Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease

Mitochondrial gene replacement in primate offspring and embryonic stem cells.

A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease

Mitochondrial DNA mutations in human disease

The dynamics of the mitochondrial organelle as a potential therapeutic target

Mitochondrial biogenesis through activation of nuclear signaling proteins

P304

1798-1817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPH.12456

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257750063

http://www.w3.org/2001/XMLSchema#string

P698

24116962

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

mitochondrial disease

P932

3976606

http://www.w3.org/2001/XMLSchema#string